Compare SUPN & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | NEOG |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2010 | 1995 |
| Metric | SUPN | NEOG |
|---|---|---|
| Price | $42.63 | $11.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $61.75 | $14.00 |
| AVG Volume (30 Days) | 566.5K | ★ 3.9M |
| Earning Date | 11-03-2026 | 10-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.20 |
| EPS | N/A | ★ N/A |
| Revenue | $392,755,000.00 | ★ $870,400,000.00 |
| Revenue This Year | $23.21 | $1.47 |
| Revenue Next Year | $54.85 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $40.51 | $5.37 |
| 52 Week High | $59.68 | $14.26 |
| Indicator | SUPN | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 44.24 |
| Support Level | $42.54 | $8.68 |
| Resistance Level | $52.33 | $12.55 |
| Average True Range (ATR) | 1.40 | 0.71 |
| MACD | 0.12 | -0.16 |
| Stochastic Oscillator | 44.81 | 1.90 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.